Fluoropharma Medical Inc (FPMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,050 | -3,164 | -4,131 | -5,607 | -4,017 |
| Depreciation Amortization | 995 | 558 | 43 | 25 | 25 |
| Accounts payable and accrued liabilities | 323 | 617 | 915 | 52 | -56 |
| Other Working Capital | 1,532 | 579 | 1,262 | 153 | -25 |
| Other Operating Activity | -1,680 | -1,267 | -1,410 | 2,046 | 792 |
| Operating Cash Flow | $-880 | $-2,677 | $-3,321 | $-3,332 | $-3,281 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -7 | -7 | -5 | -41 |
| Sale Of Investment | N/A | 36 | 569 | 1,806 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -350 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -350 | 0 | 0 |
| Investing Cash Flow | $-1 | $29 | $212 | $1,801 | $-41 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 725 | 3,345 | 2,078 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 330 | N/A |
| Debt Repayment | -100 | -490 | -25 | -55 | N/A |
| Common Stock Issued | N/A | N/A | 293 | 574 | 1,361 |
| Other Financing Activity | -10 | -169 | -128 | 521 | 0 |
| Financing Cash Flow | $615 | $2,686 | $2,218 | $1,370 | $1,361 |
| Beginning Cash Position | 291 | 252 | 1,143 | 1,304 | 3,265 |
| End Cash Position | 25 | 291 | 252 | 1,143 | 1,304 |
| Net Cash Flow | $-266 | $39 | $-891 | $-161 | $-1,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -880 | -2,677 | -3,321 | -3,332 | -3,281 |
| Capital Expenditure | -1 | -7 | -7 | -5 | -41 |
| Free Cash Flow | -881 | -2,684 | -3,328 | -3,337 | -3,322 |